Characteristics of a Subset of Patients With Reversible Systolic Dysfunction in Chronic Kidney Disease

Congestive Heart Failure

Volumn 17, Issue 3, 2011, Pages 120-126

  Adhyapak, Srilakshmi M ^a   Iyengar, Shamanna S ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TROPONIN I;

ADULT; ARTICLE; CARDIOMYOPATHY; CHRONIC KIDNEY DISEASE; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FUNCTION; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION; UREMIC CARDIOMYOPATHY;

ADULT; C-REACTIVE PROTEIN; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SYSTOLE; TROPONIN I; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79957496436     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2011.00214.x     Document Type: Article

References (24)

1. Curtis BM, Parfrey PS. Congestive heart failure in chronic kidney disease: disease specific mechanisms of systolic and diastolic heart failure and management. Cardiol Clin. 2005;23:275-284.
2. London GM, Fabiani F, Marchais SJ. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int. 1987;31:973-980.
3. Ikram H, Lynn KL, Bailey RR, Little PJ. Cardiovascular changes in chronic hemodialysis patients. Kidney Int. 1983;24:371-376.
4. Hung J, Harris PJ, Uren RF, et al. Uremic cardiomyopathy-effect of hemodialysis on left ventricular function in end-stage renal failure. N Engl J Med. 1980;302:547-551.
5. Chan C, Floras JS, Miller JA, Pierratos A. Improvement in ejection fraction by nocturnal hemodialysis in end-stage renal failure patients with co existing heart failure. Nephrol Dial Transplant. 2002;17:1518-1521.
6. Toz H, Ozkahya M, Ozerkan F, et al. Improvement in uremic cardiomyopathy by persistent ultrafiltration. Hemodial Int. 2007;11:46-50.
7. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461-470.
8. Schiller NB, Shah PM, Crawford M. Recommendations for quantitation of the left ventricle by two dimensional echocardiography. American Society of Echocardiography Committee on standards, sub committee on quantitation of two dimensional echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
9. Waggoner AD, Bierig SM. Tissue Doppler imaging: a useful echocardiographic method for the cardiac sonographer to assess systolic and diastolic ventricular function. J Am Soc Echocardiogr. 2001;14:1143-1152.
10. Jiro A, Yugi I, Hiroyashi N, et al. Clinical and pathological characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int. 2005;67:333-340.
11. Parfrey PS, Foly RN, Harnett JD, et al. Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant. 1996;11:1277-1285.
12. McLaurin MD, Apple FS, Voss EM, et al. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem. 1997;43:976-982.
13. Tun A, Khan IA, Win MT. Specificity of cardiac troponin I and creatinine kinase MB iso enzyme in asymptomatic long term hemodialysis patients and effect of hemodialysis on these cardiac markers. Cardiology. 1998;90:280-285.
14. Collinson PO, Hadcocks L, Foo Y. Cardiac troponins in patients with renal dysfunction. Ann Clin Biochem. 1998;35:380-386.
15. Sharma R, Gaze DC, Pellerin D, et al. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart. 2006;92:804-809.
16. Kennedy D, Omran E, Periyasamy SM, et al. Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J Am Soc Nephrol. 2003;14:90-97.
17. Harnett JD, Parfrey PS, Gault MH. Left ventricular hypertrophy in end stage renal disease. Nephron. 1988;48:107-115.
18. Mallamaci F, Zoccali C, Parlongo S, et al. Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients. Kidney Int. 2002;62:1884-1890.
19. Smith SC, Ladensen JH, Mason JW. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation. 1997;95:163-168.
20. Wu AH. Increased troponins in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med. 2001;27:959-961.
21. Arici M, Walls J. End stage renal disease, atherosclerosis and cardiovascular mortality: is C reactive protein the missing link? Kidney Int. 2001;59:407-414.
22. Ortega O, Rodrigues I, Gallar P, Carreno A. Significance of high C reactive protein levels in pre-dialysis patients. Nephrol Dial Transplant. 2002;17:1105-1109.
23. Khan IA, Tun A, Wattanasuwan N. Elevation of cardiac troponin I in non cardiac and cardiac diseases other than acute coronary syndromes. Am J Emerg Med. 1999;17:225-229.
24. Rigatto C, Parfrey PS. Uremic cardiomyopathy: an overload cardiomyopathy. J Clin Basic Cardiol. 2001;4:93-95.